FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases.
FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases.
复制标题
DOI:
10.3389/fendo.2014.00107
复制
发表时间:
2014
影响因子:
5.2
通讯作者:
Itoh N
中科院分区:
文献类型:
--
作者:
Itoh N
Fibroblast growth factor (FGF) family members are mostly secreted as signaling proteins with diverse functions in development and metabolism. FGF21 is a unique FGF with metabolic, but not proliferative activities. FGF21 is mostly induced by different kinds of stress and acts though FGF receptor 1c with β-Klotho as a cofactor in an endocrine or, in parts, autocrine/paracrine manner. Hepatic FGF21 directly acts on white adipocytes to inhibit lipolysis and acts through the brain to increase systemic glucocorticoid levels and suppress physical activity in response to starvation. It also protects against dioxin toxicity. Adipocytic FGF21 induces the browning of white adipose tissue (WAT) and activates brown adipocytes in response to cold exposure. It also acts as an upstream effector of adiponectin in white adipocytes. Myocytic FGF21 protects against diet-induced obesity and insulin resistance, induces the browning of WAT, and protects against cardiac hypertrophy. In addition, Fgf21 polymorphisms are possibly related with metabolic diseases and FGF21 are biomarker of metabolic diseases. These findings indicate that FGF21 plays roles as a hepatokine, adipokine, and myokine in metabolism, injury protection, and diseases.
登录
查看更多内容
影响因子:
5.2
作者:
Luo Y;McKeehan WL
通讯作者:
McKeehan WL
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
3.7
作者:
Lin Z;Wu Z;Yin X;Liu Y;Yan X;Lin S;Xiao J;Wang X;Feng W;Li X
通讯作者:
Li X
影响因子:
3.8
作者:
Stepan, Holger;Kley, Karoline;Fasshauer, Mathias
通讯作者:
Fasshauer, Mathias
影响因子:
3.8
作者:
Cheng, Xingguo;Vispute, Saurabh G.;Liu, Jie;Cheng, Christine;Kharitonenkov, Alexei;Klaassen, Curtis D.
通讯作者:
Klaassen, Curtis D.